Editorial Board

Editorial Board

David  N. (Dave) Gilbert, M.D. is emeritus faculty of Infectious Diseases at Providence Portland Medical Center in Portland Oregon, where he has practiced medicine for over 50 years. He is also Professor of Medicine at Oregon Health Sciences University. Dave did his infectious diseases fellowship training with Jay P. Sanford, M.D., at the University of Texas Southwestern Medical School in Dallas, TX, in the 1970s. His association with the Sanford Guide extends back to its first edition. Dr. GIlbert served as IDSA President in 2002. Full bio.

Henry F. (Chip) Chambers, M.D. is Director of Clinical Research Services and Professor of Medicine at the University of California San Francisco (UCSF). He earned his undergraduate degree at Vanderbilt University and his medical degree at UCSF. Chip was an infectious diseases fellow under Merle A. Sande, M.D.His academic interests include antimicrobial resistance; genetics, molecular basis, and epidemiology of methicillin-resistant Staphylococcus aureus; staphylococcal infections and tuberculosis. He joined the editorial board in 2007. Full bio.

Michael S. Saag, M.D. is Associate Dean for Global Medicine, Professor of Medicine, and Director of the Center for AIDS Research at the University of Alabama at Birmingham. Dr. Saag is an internationally recognized AIDS expert and served as HIV Medicine Association member of the IDSA Board of Directors. He joined the editorial board in 2007. Full bio.

Andrew T. (Andy) Pavia, M.D. is Professor of Pediatrics & Medicine and Chief of Pediatric Infectious Diseases at University of Utah School of Medicine in Salt Lake City. Dr. Pavia's interests have focused on HIV/AIDS and the epidemiology of emerging infections and vaccine-preventable diseases. He serves as Co-Chair of the Pandemic Influenza Task Force of the IDSA. He has served as a contributing editor since 2003 and has expanded his role in 2013 to fully cover pediatrics content. Full bio.

Douglas Black, Pharm.D. is Professor of Pharmacy at the University of Washington in Seattle, WA. Doug's expertise is in the field of pharmacology of anti-infective agents. He joined the editorial board as a contributor in 2012, and is also the principal author of The Sanford Guide's monthly ID Update e-newsletter. Full bio.

Helen Boucher, M.D. is the Dean ad interim and Professor of Medicine at Tufts University School of Medicine and Chief Academic Officer of the Wellforce Health System. An active Infectious Diseases physician, she was previously Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, and Director of the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance (Levy CIMAR). Full bio.

David O. Freedman, M.D. is Professor Emeritus of Infectious Diseases, University of Alabama at Birmingham. His academic interests cover the field of tropical and parasitic diseases as well as biosurveillance of infectious diseases in returned travelers. David joined the editorial board as a contributor in 2012. Full bio.

Kami Kim, M.D. is Professor of Internal Medicine and Director, Division of Infectious Diseases and International Medicine, at Morsani College of Medicine, University of South Florida, Tampa. Her laboratory work focuses on the pathogenesis of toxoplasmosis and malaria. She is also interested in understanding host response to parasitic infections, opportunistic pathogens, and tuberculosis. She is a graduate of Harvard University and Columbia College of Physicians and Surgeons. Full bio.

Brian S. Schwartz, M.D. is Professor and Vice Chair of Clinical Services and Program Director for the Infectious Diseases Fellowship in the Division of Infectious Diseases at the University of California San Francisco (UCSF).  His academic focus is infections in immunocompromised (non-HIV) and transplant patients. Brian joined the editorial board as a contributor in 2012. Full bio.